Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma
José R. Cortés, Christina C. Patrone, S. Aidan Quinn, et al.
Journal of Investigative Dermatology (2021) Vol. 141, Iss. 12, pp. 2908-2920.e7
Open Access | Times Cited: 21

Showing 21 citing articles:

Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome
Chella Krishna Vadivel, Andreas Willerslev-Olsen, Martin R. J. Namini, et al.
Blood (2024) Vol. 143, Iss. 15, pp. 1496-1512
Open Access | Times Cited: 15
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer
Al‐Hassan M. Mustafa, Oliver H. Krämer
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 35-61
Closed Access | Times Cited: 23
Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer
Fahim Anwar Rizwi, Md. Abubakar, Eswara Rao Puppala, et al.
Journal of Environmental Pathology Toxicology and Oncology (2023) Vol. 42, Iss. 4, pp. 15-29
Closed Access | Times Cited: 13
RuBi-Ruxolitinib: A Photoreleasable Antitumor JAK Inhibitor
Estefanía Rafic, Cindy Ma, Bobby B. Shih, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 19, pp. 13317-13325
Closed Access | Times Cited: 5
Romidepsin and Afatinib Abrogate Jak–Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma
Bobby B. Shih, Cindy Ma, José R. Cortés, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 7, pp. 1579-1589.e8
Open Access | Times Cited: 4
T cells in the skin: Lymphoma and inflammatory skin disease
Ben Roediger, Christoph Schlapbach
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 4, pp. 1172-1184
Open Access | Times Cited: 18
Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas
Karol Kołkowski, Magdalena Trzeciak, Małgorzata Sokołowska‐Wojdyło
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13388-13388
Open Access | Times Cited: 21
Cantharidin overcomes IL-2Rα signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species
Man Zhu, Wenjun Tang, Xiaoyu Tang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009099-e009099
Open Access | Times Cited: 3
Response to Chlormethine/Mechlorethamine gel Maintenance Treatment Regimen in Patients With Mycosis Fungoides: A Single-center Retrospective Study
Emily Correia, Shalini Krishnasamy, Jayson G. Suriano, et al.
Clinical Lymphoma Myeloma & Leukemia (2022) Vol. 22, Iss. 8, pp. 581-588
Closed Access | Times Cited: 13
Epigenetics: Mechanisms, potential roles, and therapeutic strategies in cancer progression
Dong Wang, Yan Zhang, Qingbo Li, et al.
Genes & Diseases (2023) Vol. 11, Iss. 5, pp. 101020-101020
Open Access | Times Cited: 7
GATA-3–dependent Gene Transcription is Impaired upon HDAC Inhibition
Xiangrong Geng, Chenguang Wang, Suhaib Abdelrahman, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 5, pp. 1054-1066
Open Access | Times Cited: 2
Revisiting epigenetic regulation in cancer: Evolving trends and translational implications
Mohammad Afsar Khan, Dhruv Mishra, Ranjan Kumar, et al.
International review of cell and molecular biology (2024), pp. 1-24
Closed Access | Times Cited: 2
Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment
Megha Yadav, Blessi N. Uikey, Shantnu Singh Rathore, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Nitrogen Mustard: a Promising Class of Anti-Cancer Chemotherapeutics – a Review
Pooja Dixit, Christine Jeyaseelan, Deepshikha Gupta
Biointerface Research in Applied Chemistry (2022) Vol. 13, Iss. 2, pp. 161-161
Open Access | Times Cited: 8
Chemotherapy
Surya K. De
Elsevier eBooks (2023), pp. 7-159
Closed Access | Times Cited: 2
Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers
Boheng Li, Qin Wan, Zhubo Li, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5147-5147
Open Access | Times Cited: 5
Therapeutic Potential of HDAC Inhibitors in the Treatment of Cardiac Diseases: A Short Review
Vikas Tiwari, S. K. Banerjee
Current Drug Targets (2022) Vol. 24, Iss. 9, pp. 718-727
Closed Access | Times Cited: 3
“Next top” mouse models advancing CTCL research
Yixin Luo, Frank R. de Gruijl, Maarten H. Vermeer, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Treatment of Sezary Syndrome with Combination Romidepsin and Tofacitinib: a Case Report
Sara Suhl, Brigit A. Lapolla, Alexander J. Kaminsky, et al.
JAAD Case Reports (2024) Vol. 55, pp. 69-72
Open Access
Skin barrier dysfunction in cutaneous T-cell lymphoma: From pathogenic mechanism of barrier damage to treatment
Pengfei Wen, Xiaoxue Zhuo, Lin Wang
Critical Reviews in Oncology/Hematology (2024) Vol. 205, pp. 104559-104559
Open Access
SnapshotDx Quiz: January 2022
Ruple Jairath, Neel S. Raval, Amy Musiek
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 1, pp. e1-e8
Open Access
Page 1

Scroll to top